Office of Cancer Survivorship

The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.

Meet the new OCS director,
Dr. Emily S. Tonorezos.

Spotlight

Publication

December 2020 — Consensus Study Report

National Academies releases consensus study report co-authored by OCS Director Dr. Emily Tonorezos: Childhood Cancer and Functional Impacts Across the Care Continuum.

Press Release

Aug. 2020 — NCI Press Release

New treatments spur sharp reduction in lung cancer mortality rate, increasing number of lung cancer survivors.

Blog

Aug. 2020 — Cancer Currents Blog

Study offers insights on health problems among adolescent and young adult cancer survivors.

Blog

July 2020 — Cancer Currents Blog

Ovarian cancer studies aim to reduce racial disparities and improve outcomes.

Blog

July 2020 — Cancer Currents Blog

Helping cancer survivors cope with cancer-related anxiety and distress.

Funding Opportunities

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors

DUE DATE: July 31, 2021

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer

DUE DATE: May 08, 2021

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization

DUE DATE: September 08, 2022

About The Office of Cancer Survivorship

An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.

OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.